Velmanase alfa-tycv: first FDA approval for non-CNS indications of alpha-mannosidosis

Published Date: 18 Feb 2023

Velmanase alfa-tycv: first FDA approval for non-CNS indications of alpha-mannosidosis

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Approved BTK Inhibitor Without Covalent Bond for CLL.

2.

High resolution ultrasound could enable faster prostate cancer diagnosis

3.

We don't all need regular skin cancer screening?but you can know your risk and check yourself

4.

Research exposes far-reaching toll of financial hardship on patients with cancer

5.

Watch for Psoriasis After Cancer Immunotherapy, Study Says


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot